But the truth is more nuanced. While there is no question that low-tar or "light" cigarettes are not safer, it is not the case that the introduction of filters made cigarettes more carcinogenic. I would not be able to testify in a courtroom that I believe filtered cigarettes are more dangerous than non-filtered cigarettes. Nor would I be able to testify that filtered cigarettes and non-filtered cigarettes pose equivalent cancer risk.

This provision is going to undermine the public's appreciation of the health hazards of smoking and prevent companies from telling consumers the truth: that e-cigarettes are a lot safer than tobacco cigarettes.

These studies are simply ignored by the Surgeon General's report and by my colleagues who have attacked me. It would be one thing if there were no evidence for my opinions, but it's hardly appropriate to attack an individual for expressing an opinion that is backed up by scientific studies.

2. Mayo Clinic Proceedings

Dr. Henningfield: "Dr. Henningfield is a Principal at, and derives most of his income from, Pinney Associates, a firm that currently provides to GSK on an exclusive basis consulting services regarding smoking-cessation products. His formal title is: Vice President, Research & Health Policy. Through his association with Pinney Associates, Dr. Henningfield advises GSK specifically on the development of nicotine-replacement therapies and treatments for tobacco dependence. Pinney Associates has received on average more than $2 million per year in revenue from pharmaceutical companies, more than half of which relates to smoking-cessation products. In addition, during the last decade, Dr. Henningfield has received grant support for research and writing from GSK on at least eight occasions. Dr. Henningfield is also a partner in a company that holds patents for a nicotine replacement-therapy product. He has estimated that, if thess patents are successfully licensed, they could be worth more than $1 million to him as a partner in that company. Thus, Dr. Henningfield has a financial interest in bringing about regulatory policies that will drive current smokers to use nicotine-replacement-therapy products."

LAST：most design electronic cigarette e luv e smart chian sex and hot e-cig e cig smart pcc |NEXT：Fast delivery tims and competitive price for e-cig liquid bottles